Shasqi, a clinical-stage biotechnology company developing click chemistry-activated oncology therapeutics, announced the additions of Steve Abella, M.D., as Chief Medical Officer and Scott Wieland, Ph.D., MBA, as Senior Vice President of Clinical Development.
May 24, 2022
· 5 min read